Supernus Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Rockville, MD
SUPN chart
What traders are saying about $SUPN
Latest postsSupernus Pharmaceuticals, Inc. news
- Supernus (SUPN) Stock Still Looks Undervalued As Its 127% 5 Year Run Continues
Yahoo Finance ·
- Supernus Pharmaceuticals Inc (S49.DU) Seasonal returns chart
Yahoo Finance UK ·
- BofA initiates Supernus Pharmaceuticals stock at buy on merger scale By Investing.com
Investing.com Australia ·
- Supernus undervalued after Indivior merger, says Bank of America
proactiveinvestors.com ·
- BofA initiates Supernus Pharmaceuticals stock at buy on merger scale
Investing.com ·
- Supernus Pharmaceuticals, Inc. (SUPN) Seasonal returns chart
Yahoo Finance UK ·
- Supernus Pharmaceuticals, Inc. (SUPN) stock price, news, quote and history
Yahoo Finance UK ·
- Supernus, Inc. (SUPN) stock price, news, quote and history
Yahoo Finance Singapore ·
- Supernus, Inc.: Performance & Quotes, SUPN Stock Price on Nasdaq Exchange
www.marketscreener.com ·
- A CEO's 958,100 trust-held Supernus (SUPN) shares convert to stock in the merger.
Stock Titan ·
- CFO Dec exchanges 9,129 Supernus (SUPN) shares for stock, with cash only for a fractional share.
Stock Titan ·
- Only fractional-share cash accompanies a Supernus (SUPN) director’s 124,119-share merger exchange.
Stock Titan ·
Supernus Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $719.0M | $661.8M | $607.5M | $667.2M |
| Net income | -$38.6M | $73.9M | $1.3M | $60.7M |
| Diluted EPS | $-0.68 | $1.32 | $0.02 | $1.04 |
| Total assets (year end) | $1.45B | $1.37B | $1.28B | $1.70B |
| Cash and equivalents (year end) | $128.4M | $69.3M | $75.1M | $93.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Supernus Pharmaceuticals, Inc.
- Ticker
- SUPN (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Rockville, MD
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1356576
- Former names
- SUPERNUS PHARMACEUTICALS INC
Frequently asked questions
What exchange is Supernus Pharmaceuticals, Inc. listed on?
Supernus Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol SUPN.
What industry is Supernus Pharmaceuticals, Inc. in?
Supernus Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Supernus Pharmaceuticals, Inc. headquartered?
Supernus Pharmaceuticals, Inc.'s business address on file with the SEC is in Rockville, MD.
When does Supernus Pharmaceuticals, Inc.'s fiscal year end?
Supernus Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Supernus Pharmaceuticals, Inc. report?
Supernus Pharmaceuticals, Inc. reported $719.0M in revenue for calendar year 2025, according to its SEC filings.